Multiplex Assay Kit for Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay)

MCAM; MUC18; Melanoma Cell Adhesion Molecule; Cell surface glycoprotein P1H12; Melanoma-associated antigen A32; S-endo 1 endothelial-associated antigen

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-99 87
EDTA plasma(n=5) 86-103 93
heparin plasma(n=5) 87-96 91
sodium citrate plasma(n=5) 80-96 91

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 89-96% 81-89% 81-90% 88-95%
EDTA plasma(n=5) 78-94% 97-105% 82-98% 97-105%
heparin plasma(n=5) 91-101% 90-101% 81-101% 85-92%
sodium citrate plasma(n=5) 85-94% 98-105% 81-96% 88-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CD146) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clinical Rheumatology Evaluation of various endothelial biomarkers in ankylosing spondylitis PubMed: 21556780
Inflammation The Effect of Regular Colchicine Treatment on Biomarkers Related with Vascular Injury in Newly Diagnosed Patients with Familial Mediterranean Fever SpringerLink: m7128503g576w808
Oncotarget Selective targeting of liver cancer with the endothelial marker CD146 Pubmed:25238265
Future Medicine Melanoma cell adhesion molecule as an emerging biomarker with prognostic significance in systolic heart failure pubmed:27355366
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB670Hu01 Active Cluster Of Differentiation 146 (CD146) Cell culture; Activity Assays.
RPB670Hu01 Recombinant Cluster Of Differentiation 146 (CD146) Positive Control; Immunogen; SDS-PAGE; WB.
PAB670Hu01 Polyclonal Antibody to Cluster Of Differentiation 146 (CD146) WB; ICC/IF
FAB670Hu01 Anti-Cluster Of Differentiation 146 (CD146) Polyclonal Antibody FCM
FAB670Hu81 FITC-Linked Anti-Cluster Of Differentiation 146 (CD146) Polyclonal Antibody FCM
RAB670Hu21 Recombinant Antibody to Cluster Of Differentiation 146 (CD146) WB; IF; ICC; IHC; IP; FCM.
MAB670Hu22 Monoclonal Antibody to Cluster Of Differentiation 146 (CD146) WB; IHC; ICC; IP.
SEB670Hu ELISA Kit for Cluster Of Differentiation 146 (CD146) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB670Hu Multiplex Assay Kit for Cluster Of Differentiation 146 (CD146) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.